Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B D Moyer

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Traffic (Copenhagen, Denmark)|February 24, 2001
Traffic pattern of cystic fibrosis transmembrane regulator through the early exocytic pathwayS I Bannykh, G I Bannykh, K N Fish, et al.
The Biochemical Journal|April 20, 2001
Differential effects of mitomycin C and doxorubicin on P-glycoprotein expressionR Maitra, P A Halpin, K H Karlson, et al.
Journal of Cell Science|February 15, 2001
A PDZ-binding motif is essential but not sufficient to localize the C terminus of CFTR to the apical membraneM I Milewski, J E Mickle, J K Forrest, et al.
The Journal of Clinical Investigation|November 24, 1999
A PDZ-interacting domain in CFTR is an apical membrane polarization signalB D Moyer, J Denton, K H Karlson, et al.
The Journal of Biological Chemistry|August 15, 1998
Membrane trafficking of the cystic fibrosis gene product, cystic fibrosis transmembrane conductance regulator, tagged with green fluorescent protein in madin-darby canine kidney cellsB D Moyer, J Loffing, E M Schwiebert, et al.
Scientific Reports|September 10, 2020
Discovery of a selective, state-independent inhibitor of Na<sub>V</sub>1.7 by modification of guanidinium toxinsH Pajouhesh, J T Beckley, A Delwig, et al.
The Journal of Biological Chemistry|June 15, 2000
The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membraneB D Moyer, M Duhaime, C Shaw, et al.
Medchemcomm|August 16, 2018
Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent Na<sub>V</sub>1.7 inhibitorsBrian A Sparling, S Yi, J Able, et al.
Molecular Pain|September 26, 2019
Rat Na<sub>V</sub>1.7 loss-of-function genetic model: Deficient nociceptive and neuropathic pain behavior with retained olfactory function and intra-epidermal nerve fibersB Grubinska, L Chen, M Alsaloum, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Traffic (Copenhagen, Denmark)|February 24, 2001
Traffic pattern of cystic fibrosis transmembrane regulator through the early exocytic pathwayS I Bannykh, G I Bannykh, K N Fish, et al.
The Biochemical Journal|April 20, 2001
Differential effects of mitomycin C and doxorubicin on P-glycoprotein expressionR Maitra, P A Halpin, K H Karlson, et al.
Journal of Cell Science|February 15, 2001
A PDZ-binding motif is essential but not sufficient to localize the C terminus of CFTR to the apical membraneM I Milewski, J E Mickle, J K Forrest, et al.
The Journal of Clinical Investigation|November 24, 1999
A PDZ-interacting domain in CFTR is an apical membrane polarization signalB D Moyer, J Denton, K H Karlson, et al.
The Journal of Biological Chemistry|August 15, 1998
Membrane trafficking of the cystic fibrosis gene product, cystic fibrosis transmembrane conductance regulator, tagged with green fluorescent protein in madin-darby canine kidney cellsB D Moyer, J Loffing, E M Schwiebert, et al.
Scientific Reports|September 10, 2020
Discovery of a selective, state-independent inhibitor of Na<sub>V</sub>1.7 by modification of guanidinium toxinsH Pajouhesh, J T Beckley, A Delwig, et al.
The Journal of Biological Chemistry|June 15, 2000
The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membraneB D Moyer, M Duhaime, C Shaw, et al.
Medchemcomm|August 16, 2018
Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent Na<sub>V</sub>1.7 inhibitorsBrian A Sparling, S Yi, J Able, et al.
Molecular Pain|September 26, 2019
Rat Na<sub>V</sub>1.7 loss-of-function genetic model: Deficient nociceptive and neuropathic pain behavior with retained olfactory function and intra-epidermal nerve fibersB Grubinska, L Chen, M Alsaloum, et al.
Pageof 2